Community Research and Development Information Service - CORDIS

Cell line development platform for SMEs to reduce the length and cost of biologic drug development

From 2016-05-01 to 2018-04-30, ongoing project

Project details

Total cost:

EUR 1 614 000

EU contribution:

EUR 1 129 800

Coordinated in:

Estonia

Call for proposal:

H2020-SMEINST-2-2015See other projects for this call

Funding scheme:

SME-2 - SME instrument phase 2

Objective

Coordinator

ICOSAGEN CELL FACTORY OU
Estonia

EU contribution: EUR 1 129 800


EERIKA TEE 1
61713 ULENURME VALD
Estonia
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Record Number: 203194 / Last updated on: 2016-04-06